You are here

Home

Clinical Trials: Urological Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, September 9, 2022 - 12:00
Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy
Condition:   Female Stress Urinary Incontinence
Intervention:   Biological: autologous muscle precursor cells
Sponsors:   University of Zurich;   GCP-Service International Ltd. & Co. KG
Not yet recruiting
Posted: Tuesday, July 19, 2022 - 12:00
The Nanofat Regenerative Surgery for Management of Genital Lichen Sclerosus in Male and Female Patients
Condition:   Urethral Stricture
Intervention:   Procedure: NANOfat grafting
Sponsors:   University of Roma La Sapienza;   University of Pisa;   Universita di Verona
Recruiting
Posted: Monday, July 11, 2022 - 12:00
Nanofat Grafting in Male and Female Subjects Affected by Urethral Strictures
Condition:   Urethral Stricture
Intervention:   Procedure: Nanofat grafting
Sponsors:   University of Roma La Sapienza;   University of Pisa
Recruiting
Posted: Thursday, May 5, 2022 - 12:00
Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
Condition:   Chronic Kidney Diseases
Intervention:   Drug: Allogeneic adipose-derived mesenchymal stem cells (MSC)
Sponsor:   LaTonya J. Hickson
Not yet recruiting
Posted: Friday, March 18, 2022 - 12:00
A Study of Renal Autologous Cell Therapy (REACT®) in Participants With Type 2 Diabetes and Chronic Kidney Disease
Conditions:   T2DM (Type 2 Diabetes Mellitus);   CKD (Chronic Kidney Disease)
Intervention:   Biological: Renal Autologous Cell Therapy (REACT®)
Sponsors:   Prokidney;   Iqvia Pty Ltd
Not yet recruiting
Posted: Tuesday, December 7, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis
Conditions:   Erectile Dysfunction;   Peyronie's Disease;   Interstitial Cystitis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Friday, October 29, 2021 - 12:00
A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Conditions:   Type 2 Diabetes Mellitus;   Chronic Kidney Diseases
Intervention:   Biological: Renal Autologous Cell Therapy
Sponsors:   Prokidney;   Iqvia Pty Ltd;   PPD
Not yet recruiting
Posted: Monday, September 13, 2021 - 12:00
Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease
Conditions:   Chronic Kidney Disease Stage 3B;   Chronic Kidney Disease stage4
Intervention:   Biological: Cellgram-CKD
Sponsor:   Pharmicell Co., Ltd.
Not yet recruiting
Posted: Tuesday, August 24, 2021 - 12:00
STUDY OF RENAL AUTOLOGOUS CELL THERAPY (REACT) IN SUBJECTS WITH TYPE 1 or 2 DIABETES AND CHRONIC KIDNEY DISEASE (REGEN-007)
Condition:   Chronic Kidney Diseases
Intervention:   Drug: Renal Autologous Cell Therapy (REACT)
Sponsor:   Prokidney
Recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD
Condition:   Chronic Kidney Diseases
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting

Pages